Olmesartan Medoxomil 40 mg Tablet

Adult dose

The recommended initial dose is 10 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 20 mg once daily. If additional blood pressure reduction is required, the dose can be increased to a maximum of 40 mg once daily. The antihypertensive effect appears within 2 weeks of starting treatment, with maximum effect occurring in about 8 weeks. If blood pressure is not controlled with this medication alone, it can be combined with thiazide diuretics like hydrochlorothiazide.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it must be stopped immediately if pregnancy is confirmed. This medicine should not be administered to individuals who are allergic to this drug or its components, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver impairment, patients with biliary obstruction, or patients with genetic issues such as lactose intolerance. Patients with decreased blood volume or salt, patients with impaired renal function, patients with renovascular hypertension, patients at risk for hyperkalemia, and patients with aortic or mitral valve stenosis must use this medication cautiously and should have their blood pressure, kidney function, and electrolyte levels regularly monitored during treatment. Dizziness may occur while taking this medication, so it is advisable to avoid hazardous machinery operations such as working at heights or driving. This medication is used for hypertension treatment and is generally safe for most patients; however, some may experience side effects such as dizziness, headache, abdominal pain, muscle pain, or rash. Rarely, serious adverse reactions may occur, such as angioedema, liver function abnormalities, hyperkalemia, or acute kidney failure, so if any unusual symptoms arise, immediate consultation with healthcare professionals is necessary. This medication may interact when used in combination with other potassium-sparing diuretics, antihypertensive agents, lithium, or nonsteroidal anti-inflammatory drugs, so it is crucial to inform your healthcare provider about any other medications being taken. In pregnant women, this drug should be avoided for the welfare of the fetus, and breastfeeding women should discontinue nursing or stop taking this medication due to potential adverse effects on infants. Safety in children has not been established, so this medication should not be administered to pediatric patients. Elderly patients may have increased drug concentration in the body, necessitating dosage adjustments and caution. In case of overdose, hypotension and palpitations may occur; if symptoms are severe, immediate contact with healthcare professionals for appropriate treatment is necessary. Long-term use of this medication has not shown any carcinogenic risk; however, if unusual symptoms develop during treatment, immediate consultation with a specialist is necessary.

Serious side effects

Urticaria, angioedema, anaphylactic reaction, hyperkalemia, acute kidney failure, liver function test abnormalities (increased transaminases or total bilirubin), urticaria, cholangitis (autoimmune hepatitis), severe allergic reactions, liver abnormalities (jaundice), respiratory problems, severe edema or urination abnormalities

Mild side effects

• Dizziness
• headache
• palpitations
• lower back pain
• bronchitis
• increased creatine kinase
• diarrhea
• hematuria
• hyperglycemia
• hypertriglyceridemia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, at a safe room temperature between 1°C and 25°C. Therefore, it is essential to store it under proper temperature and environmental conditions to maintain the medication's efficacy and prevent degradation.

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle